Trademark Overview
On Monday, May 17, 2021, a trademark application was filed for CRISPR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CRISPR THERAPEUTICS trademark a serial number of 90715256. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by CRISPR Therapeutics AG. The CRISPR THERAPEUTICS trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:
Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to i...
